{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:50:55Z","timestamp":1791305455908,"version":"4.3.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2023-149544OB-C22"],"award-info":[{"award-number":["PID2023-149544OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431C 2024\/09"],"award-info":[{"award-number":["ED431C 2024\/09"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["AP180872022"],"award-info":[{"award-number":["AP180872022"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Dysphagia in neurological patients complicates oral drug administration. Manual preparation of lozenges\/troches lacks precision and scalability. This study investigates the feasibility of implementing a pharmaceutical 3D printer in a hospital pharmacy for the automated production of personalized baclofen troches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Baclofen troches were manufactured in a hospital pharmacy setting, both manually and via pharmaceutical 3D printer. Quality was evaluated using Process Analytical Technologies (PAT). Performance was assessed through European Pharmacopoeia (EP) tests for drug content, mass uniformity,\n                      <jats:italic>in<\/jats:italic>\n                      <jats:italic>vitr<\/jats:italic>\n                      <jats:italic>o<\/jats:italic>\n                      dissolution, disintegration, and a six-month stability study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Printed troches complied with all EP acceptance criteria for drug content and mass uniformity, whereas manual formulations failed, particularly at the lowest dose. Printed troches demonstrated immediate drug release, consistent quality across batches, and remained stable for six months. 3D printing showed superior precision over traditional manual compounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This research describes the first successful implementation of an automated blister-filling workflow using a pharmaceutical 3D printer within a hospital pharmacy setting, spanning from manufacturing and dispensing to direct patient administration. The automated approach provides a significant advancement in personalized medicine, ensuring safer, more accurate, and efficient treatment options for patients with specific needs like dysphagia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11095-026-04164-7","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:41:12Z","timestamp":1786477272000},"page":"3411-3425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["On-Demand Hospital Manufacturing of Baclofen Lozenges Using Pharmaceutical 3D Printing"],"prefix":"10.1007","volume":"43","author":[{"given":"Daniel","family":"Grandal-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bendicho-Lavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Diaz-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Sanin-Fontela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"de Castro-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gonzalez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonzalez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ruiz-Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marival","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Garcia-Salom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alvarez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Goyanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"4164_CR1","unstructured":"Colegio Oficial de Farmac\u00e9uticos de Madrid. \u00bfQu\u00e9 es la disfagia? [Internet]. Colegio Oficial de Farmac\u00e9uticos de Madrid. 2021. [cited 2024 Dec 11]. Available from: https:\/\/www.cofm.es\/es\/blog\/que-es-la-disfagia\/."},{"key":"4164_CR2","unstructured":"World Gastroenterology Organisation. Dysphagia. 2021. Available from: https:\/\/www.worldgastroenterology.org\/. Accessed 12 Dec 2024."},{"key":"4164_CR3","doi-asserted-by":"crossref","unstructured":"A Satyanarayana D, Kulkarni P, G Shivakumar GH. Gels and jellies as a dosage form for dysphagia patients: a review. Curr Drug Ther. 2011;6(2):79\u201386.","DOI":"10.2174\/157488511795304921"},{"issue":"2","key":"4164_CR4","first-page":"97","volume":"48","author":"P Kahrilas","year":"1994","unstructured":"Kahrilas P. Anatomy, physiology and pathophysiology of dysphagia. Acta Otorhinolaryngol Belg. 1994;48(2):97\u2013117.","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"4164_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107326","author":"S Ramos","year":"2025","unstructured":"Ramos S, Vignes M, Secretan P-H, Legrand F-X, Annereau M, Do B. Hybrid GPP\u2013hospital control strategy for semi-solid extrusion 3D printing of ONC201 chewable units in pediatric oncology. Eur J Pharm Sci. 2025. https:\/\/doi.org\/10.1016\/j.ejps.2025.107326.","journal-title":"Eur J Pharm Sci"},{"key":"4164_CR6","doi-asserted-by":"crossref","unstructured":"Schiele J, Quinzler R, Klimm H-DK, Pruszydlo MH, Haefeli  WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69:937\u201348","DOI":"10.1007\/s00228-012-1417-0"},{"issue":"3","key":"4164_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1741-6612.2002.tb00432.x","volume":"21","author":"L Paradiso","year":"2002","unstructured":"Paradiso L, Roughead E, Gilbert A, Cosh D, Nation R, Barnes L, et al. Crushing or altering medications: what\u2019s happening in residential aged\u2010care facilities? Australas J Ageing. 2002;21(3):123\u20137.","journal-title":"Australas J Ageing"},{"issue":"1","key":"4164_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1440-172X.2009.01814.x","volume":"16","author":"\u00d8 Kirkevold","year":"2010","unstructured":"Kirkevold \u00d8, Engedal K. What is the matter with crushing pills and opening capsules? Int J Nurs Pract. 2010;16(1):81\u20135.","journal-title":"Int J Nurs Pract"},{"key":"4164_CR9","unstructured":"Food and Drug Administration FDA [cited 2025 Jan 24]. Available from: https:\/\/www.fda.gov\/drugs\/guidance-compliance-regulatory-information\/human-drug-compounding."},{"key":"4164_CR10","doi-asserted-by":"publisher","unstructured":"Carvalho M, Taylor K, Tuleu C. PP-006 Extemporaneously compounded oral medicines in Spanish hospital pharmacies. Eur J Hosp Pharm. 2014;21(Suppl 1):A124\u2013A124. https:\/\/doi.org\/10.1136\/ejhpharm-2013-000436.305.","DOI":"10.1136\/ejhpharm-2013-000436.305"},{"issue":"9","key":"4164_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091091","volume":"15","author":"M Carvalho","year":"2022","unstructured":"Carvalho M, Almeida I. The role of pharmaceutical compounding in promoting medication adherence. Pharmaceuticals (Basel). 2022;15(9): 1091.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4164_CR12","unstructured":"Food and Drug Administration. Compounding when drugs are on FDA\u2019s drug shortages List 2024. Available from: https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/compounding-when-drugs-are-fdas-drug-shortages-list#:%E2%88%BC:text=If%20your%20medical%20needs%20cannot,safety%2C%20effectiveness%2C%20or%20quality. Accessed 27 Jan 2025."},{"key":"4164_CR13","unstructured":"Commission E. Good Manufacturing Practice (GMP) Guidelines. Available from: https:\/\/health.ec.europa.eu\/medicinal-products\/eudralex\/eudralex-volume-4_en.\u00a0 Accessed 27 Jan 2025."},{"issue":"1","key":"4164_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1017\/dmp.2015.137","volume":"10","author":"KM Abbas","year":"2016","unstructured":"Abbas KM, Dorratoltaj N, O\u2019Dell M, Bordwine P, Kerkering TM, Redican KJ. Clinical response, outbreak investigation, and epidemiology of the fungal meningitis epidemic in the United States: systematic review. Disaster Med Public Health Prep. 2016;10(1):145\u201351.","journal-title":"Disaster Med Public Health Prep"},{"key":"4164_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-013-0005-9","volume":"13","author":"J Gudeman","year":"2013","unstructured":"Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13:1\u20138.","journal-title":"Drugs R D"},{"key":"4164_CR16","unstructured":"Choursiya S, Andheriya D. Review on lozenges. J Drug Deliv Ther. 2018;8(6-A):124\u20138."},{"key":"4164_CR17","volume":"66","author":"J Su\u00e1rez-Gonz\u00e1lez","year":"2021","unstructured":"Su\u00e1rez-Gonz\u00e1lez J, Magari\u00f1os-Trivi\u00f1o M, D\u00edaz-Torres E, C\u00e1ceres-P\u00e9rez AR, Santove\u00f1a-Est\u00e9vez A, Fari\u00f1a JB. Individualized orodispersible pediatric dosage forms obtained by molding and semi-solid extrusion by 3D printing: A comparative study for hydrochlorothiazide. J Drug Deliv Sci. 2021;66: 102884.","journal-title":"J Drug Deliv Sci"},{"issue":"1","key":"4164_CR18","doi-asserted-by":"publisher","DOI":"10.1515\/pthp-2023-0012","volume":"9","author":"M Magari\u00f1os-Trivi\u00f1o","year":"2024","unstructured":"Magari\u00f1os-Trivi\u00f1o M, Monz\u00f3n-Rodr\u00edguez C, Caiazzo-Lima JA, Santove\u00f1a-Est\u00e9vez A, Fari\u00f1a JB. Paediatric orodispersible lozenges produced by moulding process: quality and stability control. Pharmaceutical Technology in Hospital Pharmacy. 2024;9(1): 20230012.","journal-title":"Pharmaceutical Technology in Hospital Pharmacy"},{"issue":"06","key":"4164_CR19","first-page":"953","volume":"6","author":"VG Gokhare","year":"2017","unstructured":"Gokhare VG, Raut D, Shinde D. A review paper on 3D-printing aspects and various processes used in the 3D-printing. Int J Eng Res Technol. 2017;6(06):953\u20138.","journal-title":"Int J Eng Res Technol"},{"key":"4164_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.addr.2021.05.003","volume":"174","author":"I Seoane-Via\u00f1o","year":"2021","unstructured":"Seoane-Via\u00f1o I, Trenfield SJ, Basit AW, Goyanes A. Translating 3D printed pharmaceuticals: from hype to real-world clinical applications. Adv Drug Deliv Rev. 2021;174:553\u201375.","journal-title":"Adv Drug Deliv Rev"},{"key":"4164_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107340","author":"M Annereau","year":"2025","unstructured":"Annereau M, Secretan P, Do B. A risk-based, QTPP-driven framework for semi-solid extrusion 3D printing of personalized medicines: integrating hospital compounding and clinical trial regulation. Eur J Pharm Sci. 2025. https:\/\/doi.org\/10.1016\/j.ejps.2025.107340.","journal-title":"Eur J Pharm Sci"},{"key":"4164_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124140","volume":"657","author":"L Rodr\u00edguez-Pombo","year":"2024","unstructured":"Rodr\u00edguez-Pombo L, de Castro-L\u00f3pez MJ, S\u00e1nchez-Pintos P, Giraldez-Montero J, Januskaite P, Duran-Pi\u00f1eiro G, et al. Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders. Int J Pharm. 2024;657: 124140.","journal-title":"Int J Pharm"},{"key":"4164_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118497","volume":"567","author":"A Goyanes","year":"2019","unstructured":"Goyanes A, Madla C, Umerji A, Pi\u00f1eiro GD, Montero J, Diaz M, et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients. Int J Pharm. 2019;567: 118497.","journal-title":"Int J Pharm"},{"key":"4164_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124306","volume":"661","author":"L Denis","year":"2024","unstructured":"Denis L, J\u00f8rgensen A, Do B, Vaz-Luis I, Pistilli B, Rieutord A, et al. Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial. Int J Pharm. 2024;661: 124306.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"4164_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2017.05.021","volume":"527","author":"A Goyanes","year":"2017","unstructured":"Goyanes A, Fina F, Martorana A, Sedough D, Gaisford S, Basit AW. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int J Pharm. 2017;527(1\u20132):21\u201330.","journal-title":"Int J Pharm"},{"key":"4164_CR26","doi-asserted-by":"crossref","unstructured":"Goyanes A, Buanz AB, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476(1\u20132):88\u201392.","DOI":"10.1016\/j.ijpharm.2014.09.044"},{"key":"4164_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jconrel.2016.05.034","volume":"234","author":"A Goyanes","year":"2016","unstructured":"Goyanes A, Amornrat U, Wang J, Basit AWGS. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. J Control Release. 2016;234:41\u20138.","journal-title":"J Control Release"},{"key":"4164_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jconrel.2021.02.027","volume":"332","author":"I Seoane-Via\u00f1o","year":"2021","unstructured":"Seoane-Via\u00f1o I, Januskaite P, Alvarez-Lorenzo C, Basit AW, Goyanes A. Semi-solid extrusion 3D printing in drug delivery and biomedicine: personalised solutions for healthcare challenges. J Control Release. 2021;332:367\u201389.","journal-title":"J Control Release"},{"key":"4164_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125251","author":"X Rodr\u00edguez-Maci\u00f1eiras","year":"2025","unstructured":"Rodr\u00edguez-Maci\u00f1eiras X, Bendicho-Lavilla C, Rial C, Garba-Mohammed K, Worsley A, D\u00edaz-Torres E, et al. Advancing medication compounding: use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125251.","journal-title":"Int J Pharm"},{"key":"4164_CR30","unstructured":"Ficha T\u00e9cnica Lioseral 10 mg comprimidos [Internet] [cited 2025 Jan 31]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/52180\/FT_52180.html#1.\u00a0 Accessed 31 Jan 2025."},{"key":"4164_CR31","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Torres E, Rodr\u00edguez-Pombo L, Ong JJ, Basit AW, Santove\u00f1a-Est\u00e9vez A, Fari\u00f1a JB, et al. Integrating pressure sensor control into semi-solid extrusion 3D printing to optimize medicine manufacturing. Int J Pharm X. 2022;4:100133.","DOI":"10.1016\/j.ijpx.2022.100133"},{"key":"4164_CR32","unstructured":"EDQM. 2.9.5.\u00a0Uniformity of mass of single-dose preparations. In: European Pharmacopoeia [Internet]. 11th ed., Suppl. 11.3. Strasbourg: EDQM; 2024 [cited 2025 May 21].\u00a02024. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/20905E.htm?highlight=on&terms%5B%5D=uniformity&terms%5B%5D=uniformity%20of%20mass%20of&terms%5B%5D=of&terms%5B%5D=mass&terms%5B%5D=uniformity%20of&terms%5B%5D=uniformity%20of%20mass&terms%5B%5D=mass%20of. Accessed 21 May 2025."},{"key":"4164_CR33","unstructured":"EDQM. 2.9.7. Friability of uncoated tablets. In: European Pharmacopoeia [Internet]. 11th ed., Suppl. 11.3. Strasbourg: EDQM; 2024 [cited 2025 May 21]. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/default\/20907E.htm."},{"key":"4164_CR34","unstructured":"EDQM. 2.9.1. Disintegration of tablets and capsules. In: European Pharmacopoeia [Internet].\u00a011th ed., Suppl. 11.8. Strasbourg: European Directorate for the Quality of Medicines & HealthCare. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/20901E.htm?highlight=on&terms%5B%5D=disintegration. Accessed 11 Jan 2026."},{"issue":"3","key":"4164_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm90030043","volume":"90","author":"E Gomaa","year":"2022","unstructured":"Gomaa E, El Deeb S, Ibrahim AE, Faisal MM. Bimodal release two-in-one clonazepam matrix lozenge tablets for managing anxiety-related disorders: formulation, optimization and in vivo evaluation. Sci Pharm. 2022;90(3): 43.","journal-title":"Sci Pharm"},{"key":"4164_CR36","unstructured":"United States Pharmacopeial Convention. Baclofen Tablets monograph. In: United States Pharmacopeia and National Formulary (USP 48\u2013NF 43) [Internet]. Rockville (MD): United States Pharmacopeial Convention; 2025. Accessed 7 Jun 2025."},{"key":"4164_CR37","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH harmonised tripartite guideline Q1A(R2): stability testing of new drug substances and products. ICH; 2003."},{"key":"4164_CR38","unstructured":"Safety Data Sheet:\u00a0Techna 20 SF\u2122 troche base w\/Bitter-Bloc technology, sweetened. [Internet]. 2020. Available from: https:\/\/pharmasd.com\/wp-content\/uploads\/2022\/02\/MSDS_-_Techna_20_SF_Troche_Base_R2.pdf.\u00a0 Accessed 5 Feb 2025."},{"key":"4164_CR39","unstructured":"Mandarin Orange Natural Food Color Powder Technical Data Sheet [Internet]. n.d. [cited 2025]. Available from: https:\/\/cdn.shopify.com\/s\/files\/1\/0272\/1392\/2413\/files\/Mandarin_Orange_Natural_Food_Color_Powder_-_Tech_Sheet_R2.pdf?v=1701983029."},{"key":"4164_CR40","unstructured":"Orange Citrus SD Natural Powder Flavor Concentrate: Technical Statement [Internet]. [cited 2025]. Available from: https:\/\/cdn.shopify.com\/s\/files\/1\/0272\/1392\/2413\/files\/Orange_Citrus_SD_Natural_Powder_Concentrate_-_Tech_Sheet_R02.pdf?v=1686769345. Accessed 5  Feb 2025."},{"issue":"1-2","key":"4164_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijpharm.2017.07.064","volume":"530","author":"A Goyanes","year":"2017","unstructured":"Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. Int J Pharm. 2017;530(1\u20132):71\u20138.","journal-title":"Int J Pharm"},{"key":"4164_CR42","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s11095-017-2273-5","volume":"34","author":"S Paul","year":"2017","unstructured":"Paul S, Sun CC. Dependence of friability on tablet mechanical properties and a predictive approach for binary mixtures. Pharm Res. 2017;34:2901\u20139.","journal-title":"Pharm Res"},{"key":"4164_CR43","unstructured":"Grandpackmachine. How pharmaceutical tablet shape impacts integrity grandpackmachine. 2025. Available from: https:\/\/grandpackmachine.com\/how-tablet-shape-impacts-integrity\/.\u00a0 Accessed 12 Nov 2025."},{"issue":"9","key":"4164_CR44","volume":"9","author":"J Saito","year":"2022","unstructured":"Saito J, Hanawa T, Ozawa A, Matsumoto T, Yoshikawa N, Harada T, et al. Stability study of baclofen in an oral powder form compounded for pediatric patients in Japan. Children (Basel). 2022;9(9): 1313.","journal-title":"Children (Basel)"},{"issue":"2","key":"4164_CR45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10953-023-01333-9","volume":"53","author":"E Pourabdollah","year":"2024","unstructured":"Pourabdollah E, Rahimpour E, Jouyban A, Fathi AA. Improved solubility of baclofen using suitable coformers. J Solution Chem. 2024;53(2):341\u201353.","journal-title":"J Solution Chem"},{"key":"4164_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1208\/s12249-008-9094-0","volume":"9","author":"H Abdelkader","year":"2008","unstructured":"Abdelkader H, Youssef AO, Salem H. Formulation of controlled-release baclofen matrix tablets II: influence of some hydrophobic excipients on the release rate and in vitro evaluation. AAPS PharmSciTech. 2008;9:675\u201383.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"4164_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4314\/jfas.v5i2.10","volume":"5","author":"KH Janardhana","year":"2015","unstructured":"Janardhana KH, Deveswaran R, Bharath S, Basavaraj BV, Madhavan V. Development of sustained release tablets containing solid dispersions of baclofen. J Fundam Appl Sci. 2015;5(2):220\u201339.","journal-title":"J Fundam Appl Sci"},{"issue":"2","key":"4164_CR48","first-page":"671","volume":"11","author":"N Khan","year":"2023","unstructured":"Khan N, Wattamwar S, Vyas P. Formulation and development of baclofen fast dissolving tablets by different techniques. International Journal of Creative Research Thoughts (IJCRT). 2023;11(2):671\u20139.","journal-title":"International Journal of Creative Research Thoughts (IJCRT)"},{"key":"4164_CR49","unstructured":"EDQM. 2.9.6. Uniformity of Content of Single-Dose Preparations. 2024 [cited 2025 May 19]. In: European Pharmacopoeia [Internet]. Strasbourg: Council of Europe. 11th ed., Suppl. 11.3. [cited 2025 May 19]. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/20906E.htm."},{"key":"4164_CR50","unstructured":"EDQM. 7. Dosage Forms. Tablets. In: European Pharmacopoeia [Internet]. Strasbourg; 2018:11.8.\u00a0 [cited 2025 May 19]. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/0478E.htm. Accessed 19 May 2025."},{"key":"4164_CR51","unstructured":"EDQM. 5.17.1. Recommendations on dissolution testing. In: European Pharmacopoeia [Internet]. Strasbourg: European Directorate for the Quality of Medicines & Health Care European Directorate for the Quality of Medicines & HealthCare. 11th ed., Suppl. 11.3. 2024. [cited 2025 May 19]. Available from: https:\/\/pheur.edqm.eu\/app\/11-8\/content\/default\/51701E.htm."},{"issue":"2","key":"4164_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ijpharm.2015.04.069","volume":"494","author":"A Goyanes","year":"2015","unstructured":"Goyanes A, Martinez PR, Buanz A, Basit AW, Gaisford S. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494(2):657\u201363.","journal-title":"Int J Pharm"},{"key":"4164_CR53","unstructured":"Aluminum H. Heat seal strength testing of pharmaceutical blister packaging. 2025. Available from: https:\/\/www.aluminumblister.com\/blog\/heat-seal-strength-testing-of-pharmaceutical-blister-packaging\/?utm_source=chatgpt.com. Accessed 9 Jan 2026."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04164-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04164-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04164-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:54:40Z","timestamp":1791302080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04164-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04164-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}